These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 28093238)
1. A model of the mitochondrial basis of bipolar disorder. Morris G; Walder K; McGee SL; Dean OM; Tye SJ; Maes M; Berk M Neurosci Biobehav Rev; 2017 Mar; 74(Pt A):1-20. PubMed ID: 28093238 [TBL] [Abstract][Full Text] [Related]
2. Attenuation of mania-like behavior in Na(+),K(+)-ATPase α3 mutant mice by prospective therapies for bipolar disorder: melatonin and exercise. Kirshenbaum GS; Burgess CR; Déry N; Fahnestock M; Peever JH; Roder JC Neuroscience; 2014 Feb; 260():195-204. PubMed ID: 24342563 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications. Scaini G; Rezin GT; Carvalho AF; Streck EL; Berk M; Quevedo J Neurosci Biobehav Rev; 2016 Sep; 68():694-713. PubMed ID: 27377693 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder. Scaini G; Andrews T; Lima CNC; Benevenuto D; Streck EL; Quevedo J Mitochondrion; 2021 Mar; 57():23-36. PubMed ID: 33340709 [TBL] [Abstract][Full Text] [Related]
5. Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes. Valvassori SS; Bavaresco DV; Feier G; Cechinel-Recco K; Steckert AV; Varela RB; Borges C; Carvalho-Silva M; Gomes LM; Streck EL; Quevedo J Psychiatry Res; 2018 Jun; 264():192-201. PubMed ID: 29653348 [TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3β in patients with bipolar I disorder: results from a prospective study. Jacoby AS; Munkholm K; Vinberg M; Joaquim HG; Talib LL; Gattaz WF; Kessing LV Bipolar Disord; 2016 Jun; 18(4):334-41. PubMed ID: 27325150 [TBL] [Abstract][Full Text] [Related]
7. The circadian system of patients with bipolar disorder differs in episodes of mania and depression. Nováková M; Praško J; Látalová K; Sládek M; Sumová A Bipolar Disord; 2015 May; 17(3):303-14. PubMed ID: 25359533 [TBL] [Abstract][Full Text] [Related]
8. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. Brietzke E; Stertz L; Fernandes BS; Kauer-Sant'anna M; Mascarenhas M; Escosteguy Vargas A; Chies JA; Kapczinski F J Affect Disord; 2009 Aug; 116(3):214-7. PubMed ID: 19251324 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Dysfunctions in Bipolar Disorder: Effect of the Disease and Pharmacotherapy. Cikankova T; Sigitova E; Zverova M; Fisar Z; Raboch J; Hroudova J CNS Neurol Disord Drug Targets; 2017; 16(2):176-186. PubMed ID: 27978794 [TBL] [Abstract][Full Text] [Related]
11. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Kunz M; Gama CS; Andreazza AC; Salvador M; Ceresér KM; Gomes FA; Belmonte-de-Abreu PS; Berk M; Kapczinski F Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1677-81. PubMed ID: 18657586 [TBL] [Abstract][Full Text] [Related]
12. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders. Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518 [TBL] [Abstract][Full Text] [Related]
13. Purinergic system dysfunctions in subjects with bipolar disorder: A comparative cross-sectional study. Bartoli F; Crocamo C; Dakanalis A; Brosio E; Miotto A; Capuzzi E; Clerici M; Carrà G Compr Psychiatry; 2017 Feb; 73():1-6. PubMed ID: 27837679 [TBL] [Abstract][Full Text] [Related]
14. Increased uric acid levels in bipolar disorder subjects during different phases of illness. Albert U; De Cori D; Aguglia A; Barbaro F; Bogetto F; Maina G J Affect Disord; 2015 Mar; 173():170-5. PubMed ID: 25462413 [TBL] [Abstract][Full Text] [Related]
15. The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. Morris G; Berk M BMC Med; 2015 Apr; 13():68. PubMed ID: 25889215 [TBL] [Abstract][Full Text] [Related]
16. Bipolar II disorder : epidemiology, diagnosis and management. Benazzi F CNS Drugs; 2007; 21(9):727-40. PubMed ID: 17696573 [TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Goldsmith DR; Rapaport MH; Miller BJ Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267 [TBL] [Abstract][Full Text] [Related]
18. Differential mitochondrial DNA copy number in three mood states of bipolar disorder. Wang D; Li Z; Liu W; Zhou J; Ma X; Tang J; Chen X BMC Psychiatry; 2018 May; 18(1):149. PubMed ID: 29801445 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder. De Berardis D; Conti CM; Campanella D; Carano A; Di Giuseppe B; Valchera A; Tancredi L; Serroni N; Pizzorno AM; Fulcheri M; Gambi F; Sepede G; Moschetta FS; Salerno RM; Ferro FM J Biol Regul Homeost Agents; 2008; 22(3):195-200. PubMed ID: 18842173 [TBL] [Abstract][Full Text] [Related]